ARCHIVES

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

Dendreon’s Provenge Approved For Prostate Cancer Treatment

April 30, 2010

Mammography: Panel Member Quits Over “One-Sided” Document

February 14, 1997

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

July 20, 2012

CCOPs Payline Set At 211, Winners Lister; NCI Will Fund Only 51 Unless More Funds Added

March 16, 1990

Massive Opposition Building To OMB Cuts; Legislative, Court Actions Predicted

February 22, 1985

How Elite Institutions Were Affected By A Decade of Constricted Funding

October 31, 2014